Autor
Matthew Royle

Matthew Royle, Ph.D.

Partner

Read More
Autor
Matthew Royle

Matthew Royle, Ph.D.

Partner

Read More

7. August 2020 | 01:00:50

Biologics and biosimilars litigation update

Tune in to the second in our 2020 webinar series on decisions in the US and Europe impacting biologics and biosimilars.

Many of the top-selling drugs worldwide are biologics and several companies are seeking to produce biosimilars to compete in these lucrative markets. However, companies continue to face a great deal of uncertainty due to unresolved legal questions involving the governing statutes and patent rights.

Session 2 of this series focuses on recent key decisions, including:

  • Recent Federal Circuit decisions involving biologics and biosimilars.
  • Updates in the US “patent thicket” antitrust litigation.
  • Recent developments in Europe including Kymab v Regeneron Supreme Court judgment in the UK.
Call To Action Arrow Image

Newsletter-Anmeldung

Wählen Sie aus unserem Angebot Ihre Interessen aus!

Jetzt abonnieren
Jetzt abonnieren

Related Insights

centrifuge-machine
Life Sciences & Healthcare

Dissecting the Regeneron v Kymab mouse case – what it says and its impact on patents

27. Juli 2020
QUICK READ

von mehreren Autoren

Klicken Sie hier für Details

Events

Alle Veranstaltungen und Webinare finden Sie auf unserer Event-Seite.